Cadrenal Therapeutics, Inc.
For the period ended Sep 24, 2025. Filed Jul 31, 2025.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Sep 24, 2025 · Filed Jul 31, 2025
CVKD$0.98-2.0%Stored close · as of Nov 6, 2026
Contents
PROXY STATEMENT
For the 2025 Annual Meeting of Stockholders to be held on September 24, 2025
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.